Skip to main content

Langer biopolymer, drug delivery startup nabs $25M+ to get approvals starting in cardio surgery

By March 17, 2016October 29th, 2024Healthcare

Langer biopolymer, drug delivery startup nabs $25M+ to get approvals starting in cardio surgery

https://www.fiercebiotech.com/medical-devices/langer-biopolymer-drug-delivery-startup-nabs-25m-to-get-approvals-starting-cardio

Tags:

M&L GROUP

We are a family investment firm that cultivates pioneering ventures into successful enterprises with passion, energy and integrity.

Hospitality
Healthcare
Shipping
Alternatives
Media room
About
Contact

Copyright © 2025 M&L Group. All Rights Reserved. | Legal.

Branding and website design by Stepworks